Gene Symbol | Gene ID | Gene Info |
---|---|---|
Trp53
|
ENSMUSG00000059552.7 | transformation related protein 53 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_69580565_69580736 | Trp53 | 245 | 0.583559 | -0.41 | 2.1e-03 | Click! |
chr11_69592251_69592634 | Trp53 | 3747 | 0.077370 | -0.37 | 6.1e-03 | Click! |
chr11_69592035_69592186 | Trp53 | 3415 | 0.081117 | -0.25 | 6.8e-02 | Click! |
chr11_69580748_69581034 | Trp53 | 486 | 0.424101 | -0.24 | 7.2e-02 | Click! |
chr11_69589282_69589579 | Trp53 | 735 | 0.368931 | 0.22 | 1.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_140439026_140439687 | 38.74 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
586 |
0.63 |
chr1_85084738_85085997 | 11.71 |
Gm18342 |
predicted gene, 18342 |
5131 |
0.1 |
chr4_129416522_129416820 | 10.27 |
Zbtb8b |
zinc finger and BTB domain containing 8b |
15858 |
0.1 |
chr16_95760046_95760387 | 10.26 |
Gm37259 |
predicted gene, 37259 |
380 |
0.85 |
chr6_87271976_87272127 | 9.67 |
Antxr1 |
anthrax toxin receptor 1 |
1808 |
0.23 |
chr15_59212497_59212648 | 9.07 |
Rpl7-ps8 |
ribosomal protein L7, pseudogene 8 |
1664 |
0.38 |
chr9_106355974_106356661 | 7.53 |
Dusp7 |
dual specificity phosphatase 7 |
12315 |
0.12 |
chr7_80208004_80208221 | 7.48 |
Gm45206 |
predicted gene 45206 |
1282 |
0.27 |
chr5_140438814_140439011 | 7.17 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
1030 |
0.4 |
chr3_52603401_52603644 | 7.09 |
Gm10293 |
predicted pseudogene 10293 |
9313 |
0.25 |
chr16_15295283_15295680 | 6.61 |
Gm21897 |
predicted gene, 21897 |
21977 |
0.21 |
chr15_11011266_11011421 | 6.48 |
Slc45a2 |
solute carrier family 45, member 2 |
10622 |
0.16 |
chr2_110085704_110086138 | 6.29 |
Ccdc34os |
coiled-coil domain containing 34, opposite strand |
35442 |
0.16 |
chr1_73307384_73307555 | 6.25 |
Gm29184 |
predicted gene 29184 |
4581 |
0.25 |
chr3_93581011_93581162 | 6.23 |
S100a10 |
S100 calcium binding protein A10 (calpactin) |
20359 |
0.11 |
chr2_168451791_168452030 | 6.22 |
Gm14234 |
predicted gene 14234 |
33336 |
0.18 |
chr11_87725724_87726211 | 6.13 |
Rnf43 |
ring finger protein 43 |
1459 |
0.24 |
chr4_57611363_57611553 | 6.08 |
Pakap |
paralemmin A kinase anchor protein |
26365 |
0.23 |
chr5_111890798_111891136 | 5.97 |
Gm42488 |
predicted gene 42488 |
53268 |
0.14 |
chr11_88770495_88770705 | 5.96 |
Gm11493 |
predicted gene 11493 |
27231 |
0.15 |
chr9_32314102_32314486 | 5.82 |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
29943 |
0.14 |
chr2_31163983_31164134 | 5.81 |
Gpr107 |
G protein-coupled receptor 107 |
8209 |
0.14 |
chr15_73246575_73246818 | 5.75 |
1700085D07Rik |
RIKEN cDNA 1700085D07 gene |
2850 |
0.22 |
chr11_98932429_98933435 | 5.69 |
Rara |
retinoic acid receptor, alpha |
4766 |
0.12 |
chr14_62144524_62144913 | 5.69 |
Gm35419 |
predicted gene, 35419 |
26408 |
0.2 |
chr8_70698268_70700333 | 5.59 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr6_94962736_94963012 | 5.57 |
4930511E03Rik |
RIKEN cDNA 4930511E03 gene |
19040 |
0.22 |
chr8_20609486_20610146 | 5.54 |
Gm21119 |
predicted gene, 21119 |
5103 |
0.19 |
chr4_156059376_156059580 | 5.54 |
Ttll10 |
tubulin tyrosine ligase-like family, member 10 |
64 |
0.77 |
chr13_37513916_37514640 | 5.51 |
Gm29590 |
predicted gene 29590 |
4560 |
0.12 |
chr16_97751934_97752138 | 5.47 |
Ripk4 |
receptor-interacting serine-threonine kinase 4 |
11751 |
0.2 |
chr9_104130296_104130447 | 5.44 |
Ackr4 |
atypical chemokine receptor 4 |
3438 |
0.14 |
chr17_12791535_12791805 | 5.40 |
Gm49959 |
predicted gene, 49959 |
10 |
0.96 |
chr16_95659513_95659851 | 5.37 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
42393 |
0.15 |
chr6_136857573_136857913 | 5.36 |
Art4 |
ADP-ribosyltransferase 4 |
10 |
0.95 |
chr3_137529888_137530557 | 5.33 |
Gm4861 |
predicted gene 4861 |
22400 |
0.2 |
chr11_85832197_85833021 | 5.27 |
Tbx2 |
T-box 2 |
58 |
0.84 |
chr16_14936552_14936972 | 5.26 |
Efcab1 |
EF-hand calcium binding domain 1 |
30097 |
0.18 |
chr15_78926535_78926864 | 5.25 |
Lgals1 |
lectin, galactose binding, soluble 1 |
26 |
0.94 |
chr12_73476646_73476883 | 5.20 |
Gm48656 |
predicted gene, 48656 |
19857 |
0.14 |
chr3_151912426_151912577 | 5.18 |
Gm25056 |
predicted gene, 25056 |
13908 |
0.15 |
chr7_141147606_141147783 | 5.16 |
Ptdss2 |
phosphatidylserine synthase 2 |
6929 |
0.08 |
chr11_60366299_60366552 | 5.15 |
Drc3 |
dynein regulatory complex subunit 3 |
13045 |
0.11 |
chr6_114988340_114988551 | 5.15 |
Vgll4 |
vestigial like family member 4 |
18451 |
0.18 |
chr16_10365923_10366097 | 5.13 |
Gm1600 |
predicted gene 1600 |
18419 |
0.14 |
chr7_130288748_130289053 | 5.12 |
Fgfr2 |
fibroblast growth factor receptor 2 |
22637 |
0.22 |
chr17_42927388_42927539 | 5.06 |
Cd2ap |
CD2-associated protein |
50798 |
0.16 |
chr8_106563981_106564138 | 4.98 |
Gm10073 |
predicted pseudogene 10073 |
9291 |
0.16 |
chr1_85243098_85243527 | 4.97 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
3085 |
0.15 |
chr3_51665709_51665860 | 4.95 |
Mgst2 |
microsomal glutathione S-transferase 2 |
4559 |
0.14 |
chr9_118862897_118863101 | 4.91 |
Itga9 |
integrin alpha 9 |
9070 |
0.18 |
chr7_128398591_128399004 | 4.89 |
Rgs10 |
regulator of G-protein signalling 10 |
5112 |
0.13 |
chr7_49553633_49553972 | 4.89 |
Nav2 |
neuron navigator 2 |
90 |
0.98 |
chr5_136531842_136531993 | 4.83 |
Gm38082 |
predicted gene, 38082 |
4560 |
0.25 |
chr2_30676522_30677628 | 4.83 |
Gm14486 |
predicted gene 14486 |
936 |
0.52 |
chr9_106371237_106371388 | 4.80 |
Dusp7 |
dual specificity phosphatase 7 |
568 |
0.65 |
chr7_80825994_80826338 | 4.78 |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
192 |
0.93 |
chr4_41064510_41064661 | 4.76 |
Gm25637 |
predicted gene, 25637 |
14365 |
0.11 |
chr11_103096734_103097241 | 4.75 |
Plcd3 |
phospholipase C, delta 3 |
4604 |
0.13 |
chr7_142650028_142650657 | 4.72 |
Igf2 |
insulin-like growth factor 2 |
2688 |
0.15 |
chr9_14662295_14662446 | 4.70 |
Gm7607 |
predicted gene 7607 |
652 |
0.54 |
chr9_104211531_104211682 | 4.70 |
Dnajc13 |
DnaJ heat shock protein family (Hsp40) member C13 |
8259 |
0.17 |
chr2_181205808_181206165 | 4.67 |
Ptk6 |
PTK6 protein tyrosine kinase 6 |
3197 |
0.12 |
chr2_102067364_102067569 | 4.67 |
Gm13920 |
predicted gene 13920 |
9879 |
0.21 |
chr16_29911241_29911392 | 4.66 |
Gm26569 |
predicted gene, 26569 |
35200 |
0.15 |
chr18_80986631_80988064 | 4.66 |
Gm27239 |
predicted gene 27239 |
109 |
0.87 |
chr1_156660339_156660655 | 4.66 |
Tor3a |
torsin family 3, member A |
2039 |
0.27 |
chr4_41055172_41055493 | 4.63 |
Gm25637 |
predicted gene, 25637 |
5112 |
0.13 |
chr11_76106987_76107138 | 4.62 |
Vps53 |
VPS53 GARP complex subunit |
14383 |
0.17 |
chr5_124966975_124967353 | 4.60 |
Rflna |
refilin A |
36057 |
0.14 |
chr4_154236119_154236270 | 4.59 |
Megf6 |
multiple EGF-like-domains 6 |
1331 |
0.38 |
chr4_75329842_75330129 | 4.59 |
Gm11255 |
predicted gene 11255 |
5484 |
0.24 |
chr11_97441844_97442087 | 4.57 |
Arhgap23 |
Rho GTPase activating protein 23 |
5680 |
0.17 |
chr1_85580713_85581405 | 4.56 |
Sp110 |
Sp110 nuclear body protein |
3219 |
0.13 |
chr2_28598572_28599148 | 4.56 |
Gm22675 |
predicted gene, 22675 |
3733 |
0.13 |
chr13_96574289_96574440 | 4.51 |
Gm46436 |
predicted gene, 46436 |
2266 |
0.2 |
chr2_170070607_170070922 | 4.50 |
Zfp217 |
zinc finger protein 217 |
60456 |
0.14 |
chr18_84771728_84771906 | 4.48 |
Gm38576 |
predicted gene, 38576 |
27750 |
0.11 |
chr18_42048357_42048536 | 4.47 |
Sh3rf2 |
SH3 domain containing ring finger 2 |
5221 |
0.24 |
chr4_44112912_44113065 | 4.44 |
Gm12504 |
predicted pseudogene 12504 |
8905 |
0.13 |
chr11_48855844_48857180 | 4.43 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr12_83721405_83721556 | 4.42 |
Psen1 |
presenilin 1 |
3159 |
0.16 |
chr8_11250098_11250357 | 4.42 |
Col4a1 |
collagen, type IV, alpha 1 |
4622 |
0.2 |
chr5_4024440_4024601 | 4.40 |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
1105 |
0.52 |
chr9_66206898_66207054 | 4.40 |
Dapk2 |
death-associated protein kinase 2 |
13771 |
0.21 |
chr2_18004287_18004438 | 4.40 |
Gm13329 |
predicted gene 13329 |
5857 |
0.13 |
chr3_96220445_96221400 | 4.39 |
H2ac20 |
H2A clustered histone 20 |
42 |
0.58 |
chr16_92744246_92744397 | 4.38 |
Runx1 |
runt related transcription factor 1 |
46993 |
0.16 |
chr8_31521237_31521413 | 4.38 |
Gm45303 |
predicted gene 45303 |
29349 |
0.21 |
chr4_156083475_156083643 | 4.38 |
Gm13648 |
predicted gene 13648 |
23757 |
0.07 |
chr8_84979246_84980613 | 4.38 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr19_8997903_8998150 | 4.37 |
Ahnak |
AHNAK nucleoprotein (desmoyokin) |
128 |
0.92 |
chr9_35529844_35530147 | 4.36 |
Gm1113 |
predicted gene 1113 |
11726 |
0.1 |
chr13_71946257_71946408 | 4.33 |
Gm40999 |
predicted gene, 40999 |
10220 |
0.24 |
chr9_54801644_54801795 | 4.33 |
Rab7-ps1 |
RAB7, member RAS oncogene family, pseudogene 1 |
23563 |
0.14 |
chr1_118873594_118873797 | 4.31 |
Gm28467 |
predicted gene 28467 |
63559 |
0.11 |
chr3_9573631_9573906 | 4.27 |
Zfp704 |
zinc finger protein 704 |
8469 |
0.25 |
chr5_44922248_44922762 | 4.25 |
4930431F12Rik |
RIKEN cDNA 4930431F12 gene |
43695 |
0.13 |
chr11_113892952_113893155 | 4.21 |
Sdk2 |
sidekick cell adhesion molecule 2 |
66834 |
0.11 |
chr14_59365472_59365623 | 4.18 |
Phf11d |
PHD finger protein 11D |
77 |
0.96 |
chr7_130340841_130340992 | 4.18 |
Gm5903 |
predicted gene 5903 |
13446 |
0.23 |
chr6_51401371_51401522 | 4.17 |
0610033M10Rik |
RIKEN cDNA 0610033M10 gene |
587 |
0.72 |
chr2_128713743_128714137 | 4.16 |
Mertk |
MER proto-oncogene tyrosine kinase |
14984 |
0.15 |
chr11_100262208_100262359 | 4.16 |
Krt17 |
keratin 17 |
1254 |
0.23 |
chr2_153161013_153161878 | 4.15 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr15_84639502_84639743 | 4.13 |
Prr5 |
proline rich 5 (renal) |
29998 |
0.16 |
chr16_34839504_34839659 | 4.13 |
Mylk |
myosin, light polypeptide kinase |
54660 |
0.14 |
chr9_67182180_67182331 | 4.11 |
Gm19299 |
predicted gene, 19299 |
48694 |
0.11 |
chr11_103900989_103901150 | 4.10 |
Gm8738 |
predicted gene 8738 |
20826 |
0.17 |
chr10_18846491_18846693 | 4.10 |
Perp |
PERP, TP53 apoptosis effector |
1572 |
0.37 |
chr5_73694340_73694518 | 4.09 |
Spata18 |
spermatogenesis associated 18 |
35168 |
0.14 |
chr13_54629246_54629412 | 4.09 |
Faf2 |
Fas associated factor family member 2 |
7491 |
0.12 |
chr19_53781358_53781549 | 4.08 |
Rbm20 |
RNA binding motif protein 20 |
11855 |
0.17 |
chr11_119211950_119212137 | 4.06 |
Gm11752 |
predicted gene 11752 |
8117 |
0.12 |
chr6_29319072_29319245 | 4.05 |
Fam71f1 |
family with sequence similarity 71, member F1 |
1 |
0.96 |
chr16_15115009_15115160 | 4.04 |
Gm7731 |
predicted gene 7731 |
102244 |
0.06 |
chr5_134913846_134914156 | 4.04 |
Cldn13 |
claudin 13 |
1525 |
0.2 |
chr15_85156170_85156533 | 4.03 |
Gm19277 |
predicted gene, 19277 |
219 |
0.92 |
chr7_116728492_116728663 | 4.03 |
Gm25423 |
predicted gene, 25423 |
37092 |
0.17 |
chr2_163398355_163398526 | 4.01 |
Jph2 |
junctophilin 2 |
447 |
0.76 |
chr10_127970351_127970537 | 4.01 |
Gm47949 |
predicted gene, 47949 |
8888 |
0.09 |
chr8_110941634_110941826 | 4.00 |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
826 |
0.47 |
chr10_68104072_68104251 | 4.00 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
32465 |
0.18 |
chr19_3665529_3665685 | 4.00 |
Lrp5 |
low density lipoprotein receptor-related protein 5 |
20949 |
0.11 |
chr7_112656145_112656626 | 3.99 |
Gm45473 |
predicted gene 45473 |
3603 |
0.2 |
chr19_36451378_36451556 | 3.98 |
F530104D19Rik |
RIKEN cDNA F530104D19 gene |
310 |
0.89 |
chr2_172862717_172863491 | 3.97 |
Gm22773 |
predicted gene, 22773 |
1237 |
0.55 |
chr9_114112206_114112601 | 3.97 |
AC157997.1 |
cartilage associated protein (Crtap) pseudogene |
4274 |
0.21 |
chr1_133695909_133696268 | 3.97 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
5793 |
0.14 |
chr12_73402301_73402656 | 3.97 |
D830013O20Rik |
RIKEN cDNA D830013O20 gene |
7079 |
0.18 |
chr2_110214412_110214579 | 3.96 |
Gm22997 |
predicted gene, 22997 |
3508 |
0.22 |
chr2_27118487_27118638 | 3.96 |
Adamtsl2 |
ADAMTS-like 2 |
13899 |
0.11 |
chr14_23689838_23689989 | 3.95 |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
39724 |
0.2 |
chr15_101232781_101232932 | 3.94 |
A330009N23Rik |
RIKEN cDNA A330009N23 gene |
7670 |
0.1 |
chr12_79846801_79847112 | 3.93 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
77777 |
0.09 |
chr7_25276016_25276193 | 3.93 |
Cic |
capicua transcriptional repressor |
2318 |
0.14 |
chr1_85625302_85625650 | 3.92 |
Sp140 |
Sp140 nuclear body protein |
7002 |
0.1 |
chr8_114958496_114958723 | 3.92 |
Gm22556 |
predicted gene, 22556 |
94304 |
0.09 |
chr12_69423243_69423406 | 3.91 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
44068 |
0.08 |
chr11_61274152_61274303 | 3.91 |
Aldh3a2 |
aldehyde dehydrogenase family 3, subfamily A2 |
6763 |
0.17 |
chr2_118533190_118533760 | 3.90 |
Bmf |
BCL2 modifying factor |
11112 |
0.16 |
chr19_32974796_32975090 | 3.90 |
Gm36860 |
predicted gene, 36860 |
5120 |
0.3 |
chr7_28850001_28850162 | 3.90 |
Lgals4 |
lectin, galactose binding, soluble 4 |
9075 |
0.08 |
chr16_85128294_85128935 | 3.88 |
Gm49226 |
predicted gene, 49226 |
20215 |
0.17 |
chr5_115071759_115071910 | 3.84 |
Sppl3 |
signal peptide peptidase 3 |
2533 |
0.15 |
chr11_64509196_64509472 | 3.84 |
Hs3st3a1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
74002 |
0.11 |
chr4_139797453_139797604 | 3.83 |
Pax7 |
paired box 7 |
35479 |
0.17 |
chr10_83895756_83896002 | 3.83 |
Gm47247 |
predicted gene, 47247 |
5973 |
0.27 |
chr4_106168829_106169029 | 3.82 |
Hspd1-ps4 |
heat shock protein 1 (chaperonin), pseudogene 4 |
31151 |
0.14 |
chr10_41594987_41595356 | 3.82 |
Ccdc162 |
coiled-coil domain containing 162 |
7418 |
0.15 |
chr6_88762559_88762722 | 3.82 |
Gm43999 |
predicted gene, 43999 |
19913 |
0.1 |
chr8_107544828_107545190 | 3.82 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
3 |
0.98 |
chr7_117256959_117257110 | 3.80 |
Gm39075 |
predicted gene, 39075 |
27427 |
0.24 |
chr14_119006528_119007145 | 3.79 |
Uggt2 |
UDP-glucose glycoprotein glucosyltransferase 2 |
119 |
0.97 |
chr2_93451615_93451868 | 3.79 |
Cd82 |
CD82 antigen |
938 |
0.4 |
chr18_80261501_80261849 | 3.78 |
Slc66a2 |
solute carrier family 66 member 2 |
1165 |
0.35 |
chr13_41345941_41346221 | 3.78 |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
13166 |
0.14 |
chr3_49667673_49667841 | 3.78 |
Gm23096 |
predicted gene, 23096 |
8994 |
0.17 |
chr2_174347204_174348264 | 3.77 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr10_82844198_82844349 | 3.76 |
Gm47073 |
predicted gene, 47073 |
8374 |
0.12 |
chr3_152467459_152467610 | 3.76 |
Zzz3 |
zinc finger, ZZ domain containing 3 |
10117 |
0.16 |
chr7_74112192_74112373 | 3.75 |
Gm45004 |
predicted gene 45004 |
68544 |
0.1 |
chr3_116119158_116119497 | 3.75 |
Vcam1 |
vascular cell adhesion molecule 1 |
1388 |
0.33 |
chr4_152625073_152626079 | 3.74 |
Gm13172 |
predicted gene 13172 |
52427 |
0.14 |
chr8_106646773_106647073 | 3.74 |
Tango6 |
transport and golgi organization 6 |
36145 |
0.13 |
chr19_57352387_57352538 | 3.73 |
Fam160b1 |
family with sequence similarity 160, member B1 |
8218 |
0.15 |
chr14_22651376_22651530 | 3.73 |
Lrmda |
leucine rich melanocyte differentiation associated |
54940 |
0.15 |
chr3_85378052_85378209 | 3.73 |
Gm42813 |
predicted gene 42813 |
49998 |
0.13 |
chr8_105799109_105799779 | 3.73 |
Ranbp10 |
RAN binding protein 10 |
27761 |
0.08 |
chr14_105369813_105369964 | 3.72 |
5430440P10Rik |
RIKEN cDNA 5430440P10 gene |
57671 |
0.1 |
chr11_87689502_87689829 | 3.71 |
Gm25968 |
predicted gene, 25968 |
4916 |
0.12 |
chr7_78918740_78918891 | 3.70 |
Isg20 |
interferon-stimulated protein |
4486 |
0.15 |
chr15_77163659_77163810 | 3.69 |
Rbfox2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
9922 |
0.14 |
chr13_112340279_112340430 | 3.69 |
Ankrd55 |
ankyrin repeat domain 55 |
21900 |
0.15 |
chr7_25832021_25832185 | 3.69 |
Gm4613 |
predicted gene 4613 |
3226 |
0.11 |
chr9_43246758_43246918 | 3.69 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
3239 |
0.2 |
chr1_162223358_162223509 | 3.69 |
Mir214 |
microRNA 214 |
65 |
0.97 |
chr5_140438620_140438783 | 3.69 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
1241 |
0.34 |
chr5_134734247_134734398 | 3.68 |
Eln |
elastin |
5216 |
0.16 |
chr6_82897462_82897613 | 3.68 |
Gm45145 |
predicted gene 45145 |
563 |
0.61 |
chr2_164430819_164431021 | 3.67 |
Sdc4 |
syndecan 4 |
12266 |
0.08 |
chr11_7227019_7227454 | 3.65 |
Igfbp3 |
insulin-like growth factor binding protein 3 |
13313 |
0.18 |
chr13_112383065_112383258 | 3.65 |
Gm48837 |
predicted gene, 48837 |
15316 |
0.15 |
chr16_11316044_11316195 | 3.64 |
Tnfrsf17 |
tumor necrosis factor receptor superfamily, member 17 |
2307 |
0.25 |
chr14_25768987_25769661 | 3.64 |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
285 |
0.88 |
chr5_122145428_122145678 | 3.64 |
Ccdc63 |
coiled-coil domain containing 63 |
4730 |
0.15 |
chr9_110765852_110766229 | 3.63 |
Myl3 |
myosin, light polypeptide 3 |
116 |
0.94 |
chr5_123364319_123364636 | 3.62 |
5830487J09Rik |
RIKEN cDNA 5830487J09 gene |
1995 |
0.15 |
chr4_150776116_150776267 | 3.61 |
Gm13049 |
predicted gene 13049 |
49542 |
0.11 |
chr8_47036614_47036956 | 3.61 |
4930579M01Rik |
RIKEN cDNA 4930579M01 gene |
1392 |
0.42 |
chr1_45761430_45761705 | 3.60 |
Gm8307 |
predicted gene 8307 |
6770 |
0.15 |
chr2_13775287_13775438 | 3.59 |
St8sia6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
17931 |
0.25 |
chr13_3831624_3831775 | 3.59 |
Calm4 |
calmodulin 4 |
6058 |
0.13 |
chr9_104361499_104361672 | 3.58 |
Gm28548 |
predicted gene 28548 |
247 |
0.91 |
chr1_193152702_193153255 | 3.57 |
Irf6 |
interferon regulatory factor 6 |
133 |
0.93 |
chr2_172933682_172934412 | 3.57 |
Bmp7 |
bone morphogenetic protein 7 |
6045 |
0.2 |
chr2_167563953_167564293 | 3.56 |
Gm11476 |
predicted gene 11476 |
10809 |
0.12 |
chr16_4881523_4881812 | 3.55 |
Ubald1 |
UBA-like domain containing 1 |
1352 |
0.3 |
chr9_120027392_120027784 | 3.55 |
Xirp1 |
xin actin-binding repeat containing 1 |
3990 |
0.12 |
chr17_27587307_27587525 | 3.55 |
Nudt3 |
nudix (nucleotide diphosphate linked moiety X)-type motif 3 |
4097 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 30.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
3.1 | 3.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.6 | 4.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 4.4 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 5.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.3 | 3.9 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.3 | 5.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.3 | 3.8 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.3 | 5.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 4.9 | GO:0060596 | mammary placode formation(GO:0060596) |
1.2 | 3.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.2 | 3.6 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.2 | 3.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.2 | 3.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.2 | 3.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.1 | 3.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.1 | 3.4 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.1 | 1.1 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
1.1 | 5.3 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.1 | 3.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.1 | 4.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.0 | 1.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.0 | 3.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.0 | 4.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.0 | 5.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.0 | 5.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.0 | 3.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 1.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.9 | 3.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 3.7 | GO:0002159 | desmosome assembly(GO:0002159) |
0.9 | 1.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.9 | 4.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.9 | 2.6 | GO:0002432 | granuloma formation(GO:0002432) |
0.9 | 3.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.9 | 1.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.9 | 2.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 3.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.8 | 2.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.8 | 2.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 0.8 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.8 | 4.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.8 | 4.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.8 | 1.6 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.8 | 2.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.8 | 3.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 2.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 3.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.8 | 2.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.7 | 2.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.7 | 2.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.7 | 2.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.7 | 2.2 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.7 | 3.6 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.7 | 2.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.7 | 3.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.7 | 1.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 2.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.7 | 3.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 2.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 2.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.7 | 2.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.7 | 2.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 2.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.7 | 2.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.7 | 2.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.7 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 1.3 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.6 | 1.9 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 2.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 1.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 3.2 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.6 | 3.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.6 | 1.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 1.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 1.2 | GO:0060592 | mammary gland formation(GO:0060592) |
0.6 | 1.9 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.6 | 1.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.6 | 3.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 5.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.6 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 3.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 2.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 2.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 1.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.6 | 1.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 0.6 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.6 | 1.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.6 | 1.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 3.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 1.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.6 | 0.6 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.6 | 1.7 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.6 | 1.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.6 | 2.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.5 | 0.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.5 | 1.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.5 | 1.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 | 2.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 4.3 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.5 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.6 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.5 | 1.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 0.5 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.5 | 1.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.5 | 1.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 5.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.5 | 4.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 2.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 1.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 2.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 1.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 5.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 5.5 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.5 | 1.0 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.5 | 2.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 9.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 1.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 2.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 1.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 2.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.5 | 1.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 3.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 10.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 1.0 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 1.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 0.5 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.5 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.5 | 1.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 2.8 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 2.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 0.9 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 1.9 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.5 | 1.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.5 | 0.9 | GO:0036166 | phenotypic switching(GO:0036166) |
0.5 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 0.9 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.5 | 2.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 1.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 1.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 5.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.5 | 0.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.5 | 1.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.4 | 1.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.4 | 1.3 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.4 | 3.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 1.3 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.4 | 3.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 1.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 4.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 4.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 1.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 4.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.4 | 1.3 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.4 | 2.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 0.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 0.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 1.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.4 | 2.1 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 8.0 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.4 | 0.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 1.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.4 | 1.2 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 2.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.4 | 2.5 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.4 | 1.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 0.8 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 2.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 0.8 | GO:0051794 | regulation of catagen(GO:0051794) |
0.4 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 2.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 2.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 2.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 1.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 0.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.4 | 3.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 0.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 3.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 1.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 1.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.4 | 0.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 1.5 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.4 | 0.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.4 | 3.0 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 3.0 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 1.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 1.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.4 | 1.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 7.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 1.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 1.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 2.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 1.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.4 | 1.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 1.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 1.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.4 | 1.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 2.6 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.4 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.4 | 1.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 2.2 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 1.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 1.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 1.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.4 | GO:0070293 | renal absorption(GO:0070293) |
0.4 | 0.7 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 0.4 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.4 | 1.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 3.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.4 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 1.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 0.7 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.4 | 2.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 1.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.4 | 0.7 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 2.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 2.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 0.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 2.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 1.4 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 1.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.7 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 1.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 3.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 2.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 3.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.7 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 3.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.3 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.0 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.3 | 1.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.3 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 1.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 2.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 | 1.0 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.3 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 2.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.3 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.3 | 6.8 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 0.6 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.3 | 1.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 0.9 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.3 | 0.3 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.3 | 2.2 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 0.6 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.3 | 0.9 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 4.1 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 4.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 1.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 2.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 2.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 0.9 | GO:0061511 | centriole elongation(GO:0061511) |
0.3 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 3.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 2.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 2.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 0.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.3 | 1.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 0.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 1.2 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 3.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.3 | 1.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 0.9 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.3 | 1.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 1.8 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 0.6 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.3 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.3 | 0.9 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 1.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 2.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 0.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 1.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.3 | 0.9 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 2.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 0.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.3 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.3 | 1.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 2.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 4.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.3 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 2.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 0.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 3.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.3 | 1.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 0.8 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 0.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 2.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 0.5 | GO:2000303 | positive regulation of sphingolipid biosynthetic process(GO:0090154) regulation of ceramide biosynthetic process(GO:2000303) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 1.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 1.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 1.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 0.5 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 1.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.3 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 1.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.5 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 0.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.3 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.3 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 1.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 1.3 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 1.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 6.8 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 3.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.3 | 0.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 4.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 4.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 1.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 2.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 2.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.2 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 0.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 3.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 1.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 1.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 1.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.2 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 1.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 5.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.2 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 9.9 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.2 | 1.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 2.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 1.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 3.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 2.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 0.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.2 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.2 | 0.5 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 3.9 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.2 | 1.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.5 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 1.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.2 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 | 0.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 3.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 2.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 7.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 0.7 | GO:0071051 | DNA deamination(GO:0045006) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 1.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 4.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.4 | GO:0072033 | ureteric bud elongation(GO:0060677) renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.9 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 2.8 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 1.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 5.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 1.7 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 1.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 3.2 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.2 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:0097490 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 2.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.4 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 3.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.2 | 0.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.2 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 1.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 4.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.4 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 1.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 1.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.2 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.2 | 2.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 3.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 1.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.6 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0032365 | intracellular lipid transport(GO:0032365) intracellular sterol transport(GO:0032366) |
0.2 | 0.6 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 1.0 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.2 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 1.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.4 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 0.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 1.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 1.3 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 0.9 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 2.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.2 | 0.6 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 1.6 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 1.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.2 | 0.2 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.2 | 2.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.4 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 3.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 1.8 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 1.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 2.9 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.9 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.2 | GO:1901300 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 0.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 1.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 3.8 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.2 | 0.7 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.2 | 1.5 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 1.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.3 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.2 | 0.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 1.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.7 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 1.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.2 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 1.8 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.3 | GO:0060045 | positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.2 | 0.3 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.2 | 1.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 0.2 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.2 | 0.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.9 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 3.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 1.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 0.3 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.2 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 1.7 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 4.7 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.3 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 1.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 0.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 1.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 1.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 1.2 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 5.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 0.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 1.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 2.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.3 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.3 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.1 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 1.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 1.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.8 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 1.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 4.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.4 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 3.0 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 4.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 1.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 2.5 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 1.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 1.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 1.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.1 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 1.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 2.0 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.4 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 2.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 1.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.4 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 1.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.2 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 1.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 2.3 | GO:0042073 | intraciliary transport(GO:0042073) |
0.1 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.1 | 0.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 3.3 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.3 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.7 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 3.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 2.2 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 1.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.7 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 1.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.4 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.1 | 0.8 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.9 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.6 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.3 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 3.0 | GO:0001889 | liver development(GO:0001889) |
0.1 | 1.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.0 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 1.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.5 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 1.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 1.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.4 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.8 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0043307 | eosinophil activation(GO:0043307) |
0.1 | 1.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 2.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 3.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.6 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.4 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.4 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.6 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 1.9 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 1.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.1 | 6.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.1 | 1.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.3 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:1903432 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 2.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.3 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.3 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.1 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 1.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.2 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 1.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:0090504 | epiboly(GO:0090504) |
0.1 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 1.7 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.7 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.1 | 0.2 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 1.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.1 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 1.8 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.1 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.7 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) negative regulation of male gonad development(GO:2000019) |
0.1 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.7 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:1903288 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.1 | 0.2 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.2 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.6 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.1 | GO:2000341 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.2 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.1 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.1 | GO:0043651 | phenylpropanoid metabolic process(GO:0009698) linoleic acid metabolic process(GO:0043651) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 2.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.5 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.1 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.1 | 0.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 1.2 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.0 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 3.0 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.0 | 0.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.0 | 0.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0071220 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.3 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 1.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.0 | 0.5 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 0.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:0097484 | dendrite extension(GO:0097484) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.5 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 2.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.1 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.3 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.3 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.0 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.5 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.0 | 0.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.3 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.0 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.0 | 0.0 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.8 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.1 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.1 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.0 | 0.3 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.0 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 2.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) positive regulation of response to alcohol(GO:1901421) |
0.0 | 1.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.0 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.0 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.0 | GO:0090656 | t-circle formation(GO:0090656) regulation of t-circle formation(GO:1904429) |
0.0 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.0 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.0 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 1.4 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.0 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.0 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 30.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.4 | 4.1 | GO:0005914 | spot adherens junction(GO:0005914) |
1.2 | 3.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.2 | 4.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 5.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.0 | 3.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 2.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.9 | 5.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.8 | 6.8 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 3.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 2.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 1.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.7 | 2.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 2.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 5.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 6.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 2.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 1.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 1.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.5 | 1.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 2.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 1.4 | GO:0031417 | NatC complex(GO:0031417) |
0.5 | 2.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 6.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 3.1 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.3 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 1.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 5.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 2.2 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 1.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 2.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 2.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 1.7 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 2.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.4 | 11.1 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 4.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 2.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 20.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 2.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 1.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 2.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 2.3 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.4 | 1.5 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 2.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 3.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 3.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 2.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 2.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 2.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 13.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 0.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 1.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 0.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 0.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 2.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 1.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 2.8 | GO:0002102 | podosome(GO:0002102) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 1.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 2.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 7.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 1.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 3.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 2.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 0.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 1.0 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 3.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 2.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 3.4 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 0.9 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 2.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.9 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 3.2 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 2.9 | GO:0043034 | costamere(GO:0043034) |
0.2 | 2.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 5.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.7 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 4.3 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 0.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 17.1 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.7 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.8 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 4.2 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 55.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 4.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 5.1 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 6.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 1.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 18.2 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.2 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 4.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 12.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 2.3 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 7.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 3.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 3.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 2.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 4.8 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 8.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 1.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 11.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 1.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 5.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 1.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 24.7 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 0.3 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 2.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 3.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 3.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 3.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 4.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.5 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 1.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 4.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 5.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.7 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 3.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 3.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.8 | GO:0030894 | replisome(GO:0030894) |
0.1 | 12.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 1.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.0 | 0.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 1.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.6 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 2.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 4.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 3.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.0 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.0 | 0.6 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 2.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.0 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 1.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.6 | GO:0016607 | nuclear speck(GO:0016607) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.6 | 4.9 | GO:0048030 | disaccharide binding(GO:0048030) |
1.4 | 5.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.2 | 5.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.1 | 3.2 | GO:0030172 | troponin C binding(GO:0030172) |
1.0 | 3.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.0 | 2.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.0 | 3.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 5.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 5.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.9 | 4.7 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.9 | 6.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 3.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.8 | 9.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.8 | 2.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.8 | 9.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 2.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 3.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.8 | 6.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.8 | 2.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 3.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.7 | 4.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 2.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 6.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.7 | 2.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 2.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 2.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 3.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 2.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.6 | 3.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 3.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 3.0 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 4.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 21.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.6 | 1.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 1.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 1.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.6 | 2.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.6 | 1.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 2.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.5 | 3.3 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.5 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 1.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.5 | 1.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.5 | 5.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 5.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 1.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 2.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 2.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 3.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 1.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.5 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 1.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 1.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.5 | 1.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 3.3 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 1.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 0.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 3.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 0.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 1.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 6.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 4.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 2.2 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 5.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 3.4 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.4 | 1.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 3.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.4 | 1.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 2.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 3.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 0.4 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.4 | 1.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 2.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 1.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.4 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 1.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 1.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 1.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 3.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.4 | 3.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 2.9 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.4 | 2.9 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 1.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 1.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 1.1 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 0.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 3.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 2.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 1.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 2.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.3 | 0.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 2.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 2.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 2.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 2.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 6.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 0.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.3 | 2.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 0.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 1.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 2.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 5.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 23.3 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 10.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 2.0 | GO:0018639 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 5.7 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.3 | 0.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.8 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.3 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.3 | 0.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 1.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 3.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 2.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.0 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.3 | 0.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 0.8 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 1.0 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 1.0 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 0.5 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.2 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 3.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 1.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 1.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 1.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 7.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 2.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 1.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 1.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 2.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 2.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 3.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 2.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.3 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.2 | 1.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 2.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 1.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 3.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 1.8 | GO:0034868 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 3.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 2.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 2.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 3.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 2.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 3.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.6 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 1.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 2.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 2.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 7.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 1.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 2.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 3.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 2.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.4 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 2.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 1.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 4.5 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.2 | GO:0097108 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
0.2 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.9 | GO:0008932 | lytic endotransglycosylase activity(GO:0008932) |
0.1 | 3.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.9 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.4 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 6.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 9.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 2.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 1.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 1.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 3.5 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.4 | GO:0043747 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 3.0 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 3.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 3.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.7 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 2.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 1.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.5 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 8.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 7.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.6 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 3.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.8 | GO:0044769 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 1.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.5 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.6 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 1.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.4 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 1.8 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 4.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 6.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 5.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 8.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.6 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 2.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 1.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.1 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.3 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 2.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 2.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 9.9 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 5.7 | GO:0008766 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 5.7 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.8 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.1 | 3.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 2.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.4 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 1.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 8.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 3.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 1.5 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 1.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 1.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.6 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.3 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 13.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 2.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 2.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 4.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.5 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 3.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.0 | 0.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.0 | 4.8 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 1.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.0 | GO:0031267 | small GTPase binding(GO:0031267) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 0.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 8.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 15.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 19.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 22.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 6.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 7.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 5.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 6.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.4 | 11.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 10.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 6.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 10.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 3.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 9.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 7.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 3.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 2.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 10.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 5.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 2.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 6.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 2.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 3.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 4.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 4.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 3.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 2.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 3.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 4.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 3.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 2.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 3.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 2.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 16.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 14.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 5.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 3.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 14.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 4.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 7.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 7.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 26.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.5 | 7.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.5 | 8.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 0.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.5 | 7.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 36.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 0.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.4 | 0.4 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.4 | 4.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 10.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 3.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 6.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 3.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.4 | 9.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 4.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 2.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 3.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 6.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 3.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 7.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 2.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 2.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 1.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 1.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 3.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 1.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 3.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 2.5 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 2.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 5.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 1.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 0.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 2.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 6.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 2.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 2.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 3.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 2.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 5.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 3.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 7.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 3.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 2.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 6.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.0 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 2.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 4.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 3.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 2.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 1.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 2.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 2.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 5.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 0.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 1.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 13.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 4.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 1.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 6.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 2.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 3.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 3.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.7 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 3.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 3.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 3.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 6.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 1.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 4.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 6.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 4.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 8.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 4.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 3.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.5 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |